FRAMINGHAM, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- Alira Health, in partnership with the Autoimmune Neurology Alliance (AiNA), today announced the launch of the AXIS Registry, a new initiative ...
Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer, ...
The California-based biotech has hired Omeros and AbbVie alum Nadia Dac as its new chief commercial officer, where she will ...
We read with great interest the recent article by Tsai et al,1 which compared characteristics between primary neuromyelitis ...
Patients with stiff person syndrome are one step closer to having access to a new treatment. Kyverna Therapeutics’ new drug, KYV-101, has been designated by the U.S. Food and Drug Administration (FDA) ...
Roche announced three major phase III trial successes across autoimmune and neurological diseases, including lupus, a rare demyelinating disorder, and multiple sclerosis. The FDA accepted its ...
About 8% of people in the United States live with an autoimmune disease, a condition in which the immune system mistakenly ...
The 62nd annual Irish Neurological Association Meeting will take place from May 14 to 15 in Clontarf Castle Hotel ...
New registry connects patients and researchers to accelerate understanding and improve care in autoimmune neurological diseases FRAMINGHAM, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- Alira Health, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results